by
Olga Deshchenko, DOTmed News Reporter | February 11, 2011
Hologic's tomosynthesis system is already on the market in more than 40 countries across the world. In North America, units have already been installed in Mexico and Canada, according to the company.
"We are extremely proud to be the first company to receive FDA approval of a 3-D digital mammography system and to offer women this ground-breaking, superior imaging technology," Rob Cascella, Hologic's president and CEO, said in prepared remarks. "Our Dimensions 3-D takes advantage of all of the benefits of digital mammography and quite simply makes it better with the combination of fast, high quality 3-D breast imaging."

Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Nearly 200,000 women will be diagnosed with breast cancer this year, according to the National Cancer Institute. If the cancer is detected early and still localized to the breast, the survival rate is 98 percent.
"We believe tomosynthesis has the potential to change how screening and diagnostic mammography is performed, and over time will prove invaluable to the earliest possible detection of breast cancer and in the reduction of unnecessary diagnostic interventions," said Cascella.
Back to HCB News